Investigation of genotypes in patients with OI type III and COL1A2 haploinsufficiency variants for presence of mutations in other OI genes is essential and current patients are included into panel sequencing cohort. This evidence concerns the gene COL1A2 and osteogenesis imperfecta type 3.